Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $10.04 in the prior trading day, Drugs Made In America Acquisition II Corp (NASDAQ: DMIIU) closed at $10.02, down -0.20%. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 0.58 million shares were traded. DMIIU stock price reached its highest trading level at $10.04 during the session, while it also had its lowest trading level at $10.0.
Ratios:
Our goal is to gain a better understanding of DMIIU by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.04 and its Current Ratio is at 0.04.
Stock Price History:
Over the past 52 weeks, DMIIU has reached a high of $10.06, while it has fallen to a 52-week low of $9.94. The 50-Day Moving Average of the stock is 0.21%, while the 200-Day Moving Average is calculated to be 0.21%.
Shares Statistics:
The stock has traded on average 1.09M shares per day over the past 3-months and 23770 shares per day over the last 10 days, according to various share statistics. A total of 63.70M shares are outstanding, with a floating share count of 51.20M. Insiders hold about 19.62% of the company’s shares, while institutions hold 11.24% stake in the company. Shares short for DMIIU as of 1761868800 were 100450 with a Short Ratio of 0.06, compared to 1759190400 on 173616.
